期刊文献+

G蛋白偶联受体48与肿瘤发生发展关系的研究进展

Research Progress in Correlation between G Protein Coupled Receptor 48 and Tumorigenesis and Development
下载PDF
导出
摘要 G蛋白偶联受体(GPCR)48属于GPCR家族,参与机体内多种生理反应的调节。随着对GPCR48研究的深入发现,其不仅在正常生长发育过程中发挥关键作用,而且还与肿瘤的发生、发展密切相关。GPCR48在多种肿瘤组织中为促癌受体,抑制肿瘤细胞中的GPCR48表达可延缓肿瘤细胞的生长及转移,是一种潜在的肿瘤治疗分子靶点。然而,GPCR48在肿瘤中的作用机制非常复杂,目前尚未明确。因此,深入研究GPCR48的表达及调控相关机制对肿瘤的诊断、治疗及预后具有重要意义。 G protein coupled receptor(GPCR)48,a member of GPCR family, is involved in the regulation of a variety of physiological responses in the human body.With the further research on GPCR48,it is found that it not only plays a key role in the process of normal growth and development, but also is closely related to the occurrence and development of tumors.GPCR48 is a cancer promoting receptor in a variety of tumor tissues, and inhibition of GPCR48 expression in tumor cells can delay the growth and metastasis of tumor cells, therefore is a potential molecular target for tumor therapy.However, the mechanism of GPCR48 is very complex and has not been clarified.Therefore, the further study to elucidate the expression and regulation mechanism of GPCR48 is of great significance for the diagnosis, treatment and prognosis of tumors.
作者 彭契六 朱春玲 PENG Qiliu;ZHU Chunling(Department of Clinical Laboratory,Guangxi International Zhuang Medicine Hospital,Nanning 530201,China)
出处 《医学综述》 CAS 2021年第17期3419-3423,共5页 Medical Recapitulate
基金 广西自然科学基金(2017JJA10583) 南宁市科学研究与技术开发计划项目(20163126) 广西中医药大学引进博士科研启动基金项目(2019BS042)。
关键词 肿瘤 G蛋白偶联受体48 G蛋白偶联受体家族 促癌受体 Tumor G protein coupled receptor 48 G protein coupled receptor family Cancer promoting receptor
  • 相关文献

参考文献5

二级参考文献30

  • 1Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 2陈明立,谭远发.我国东中西部三大区域人口竞争力实证比较研究[J].经济学家,2007(2):53-63. 被引量:6
  • 3Carmon, K.S., Gong, X., Lin, Q., Thomas, A., and Liu, Q. (2011). R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Nat Acad Sci USA 108, 11452-11457.
  • 4Hanada, R., Hanada, T., Sigl, V., Schramek, D., and Penninger, J.M. (2011). RANKL/RANK-beyond bones. J Mol Med (Bed). 89, 647-656.
  • 5Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C.R., Lacey, D.L, Mak, T.W., Boyle, W.J., and Penninger, J.M. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
  • 6Luo, J., Yang, Z., Ma, Y., Yue, Z., Lin, H., Qu, G., Huang, J., Dai, W., Li, C., Zheng, C., Xu, L., Chen, H., Wang, J., Li, D., Siwko, S., Penninger, J.M., Ning, G., Xiao, J., and Liu, M. (2016). LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Nat Med doi: 10.1038/nm.4076.
  • 7Luo, J., Zhou, W., Zhou, X., Li, D., Weng, J., Yi, Z., Cho, S. G., Li, C., Yi, T., Wu, X., Li X.Y., de Crombrugghe B., Hook M., and Liu, M. (2009). Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development 136, 2747-2756.
  • 8苌凤水,罗力,王环增,张闽元,宋峻,段勇,张爱莉,高解春,常军,张为佳,陈海娟,姚震涛,毛庭龙,马红兵,孙明,周锦颢,杨保利,花庆华,刘昕,马安宁,张晓乙,陈政,李路勇,郭杏雅,黄慧玲,杨小川,王卫华,郝模.我国公立医疗机构职工流动现状分析[J].中国医院管理,2008,28(1):26-28. 被引量:6
  • 9高芸,单忠艳,王红,张红梅,滕卫平.靶向GPR48的shRNA抑制人宫颈癌HeLa细胞的侵袭转移[J].癌症,2009,28(2):126-130. 被引量:5
  • 10彭文斌,刘友金.我国东中西三大区域经济差距的时空演变特征[J].经济地理,2010,30(4):574-578. 被引量:90

共引文献1054

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部